Health
Selecting SARS-CoV-2 inhibitors in human airway epithelial cells – News-Medical.Net
In a recent article currently available on the bioRxiv* preprint server, researchers from Belgium and the U.S. demonstrated a robust replication model for the severe…
In a recent article currently available on the bioRxiv* preprint server, researchers from Belgium and the U.S. demonstrated a robust replication model for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolates in primary human epithelial cells at the air-liquid interface and appraised the antiviral effect of selected viral replication inhibitors.
The vaccination campaign is our current answer against the ongoing spread of SARS-CoV-2 and coronavirus disease (COVID-19) pandemic….
-
General21 hours agoAustralia’s native flora emerges as an increasingly popular muse for bonsai hobbyists
-
Noosa News19 hours agoFears for the future of retro Chinese dining after blaze guts Sundoo in Townsville
-
General15 hours agoFears super tax rise for rich will whack housing market
-
General15 hours agoNRL live: New Zealand Warriors face Canberra Raiders, Liam Henry, Ronaldo Mulitalo facing bans